Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
12,547,614
-
Share change
-
+6,752,935
-
Total reported value
-
$12,776,470
-
Put/Call ratio
-
125%
-
Price per share
-
$0.94
-
Number of holders
-
50
-
Value change
-
+$6,594,245
-
Number of buys
-
27
-
Number of sells
-
9
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q1 2021
As of 31 Mar 2021,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,547,614 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MILLENNIUM MANAGEMENT LLC, Virtu Financial LLC, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, and MORGAN STANLEY.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.